Iovance Biotherapeutics

Maria Fardis, President and CEO
USA | Funding: $1.6B (+)
Website: http://www.iovance.com/
IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL)
Website: http://www.iovance.com/
IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL)

